The global orthobiologics market is projected to reach USD 6.06 Billion by 2022 from USD 4.66 Billion in 2017, at a CAGR of 5.4% during forecast period. Factors like rising burden of orthopedic injuries; increasing incidence of sports injuries and road accidents; increasing incidence of spinal fusion surgeries; risk factors associated with increasing aging population, obesity rate, & high incidence of musculoskeletal disorders.
- Advertising -
Download Brochure of Orthobiologics Market spread across 159 Pages, Profiling 15 Companies and Supported with 60 Tables and 38 Figures is now available at www.rnrmarketresearch.com/contacts…ple?rname=1209993 .
The orthobiologics market has been categorized into the following segments: fracture recovery, osteoarthritis & degenerative arthritis, spinal fusion, soft-tissue injuries, and maxillofacial & dental applications. Amongst these, spinal fusion segment is expected to grow at highest CAGR during forecast period owing to factors like rising number of spinal fusion procedures, increasing adoption of allografts.
Key Audience of This Market as Follows:
- Orthobiologics Product Manufacturing Companies
- Product Suppliers, Distributors, and Channel Partners
- Hospitals and Ambulatory Care Centers
- Orthopedic and Dental Clinics
- Research Laboratories and CROs
- Research and Academic Institutes
- National and International Regulatory Authorities
- Government and Non-government Organizations
- Market Research Firms
The orthobiologics market into product, application, and end user.
- Advertising -
On the basis of product, market is categorized into allografts, synthetic orthobiologics, PRP, BMAC, DBM, BMP, and viscosupplementation products. In 2017, viscosupplementation products segment is expected to account for largest share of market.
Large share of this segment can be attributed to increasing incidence of osteoarthritis of the knee and hip joints among the baby boomer population and lower cost of viscosupplementations.
Report at www.rnrmarketresearch.com/contacts/1209993 .
Orthobiologics market report broadly segments orthobiologics market into product, application, & end user. On basis of product, market is categorized into allografts, synthetic orthobiologics, PRP, BMAC, DBM, BMP, and viscosupplementation products.
Large share of this segment can be attributed to increasing incidence of osteoarthritis of knee & hip joints among baby boomer population and lower cost of viscosupplementations.
Breakdown of supply-side primary interviews:
- By Company Type - Tier 1 – 25%, Tier 2 – 30% and Tier 3 – 45%
- By Designation – – C-level – 26%, Director level – 30%, Others – 44%
- By Region – North America - 34%, Europe – 26%, APAC – 23%, RoW – 17%
The orthobiologics market is segmented into North America, Europe, Asia Pacific, and RoW. The Asia Pacific market is expected to register the highest growth rate during the forecast period.
The presence of a large geriatric and target patient population, high incidence of osteoarthritis and obesity, increasing government spending on healthcare, and improving healthcare infrastructure are some of the major factors driving the growth of the Asia Pacific orthobiologics market.
“Hospitals, orthopedic clinics, and ambulatory care centers are expected to be the fastest-growing segment.” On the basis of end user, the market is segmented into hospitals, orthopedic clinics, and ambulatory care centers; research &academic institutes; and dental clinics and facilities. The hospitals, orthopedic clinics, and ambulatory care centers segment is expected to grow at the highest rate during the forecast period.
Category: Market Research Publishers and RetailersCompany profile: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
For more information: